I wish I knew! My leading hypothesis is that (a) we still need to prove ourselves more with the money we have received and (b) I’ve done a bad job explaining how we would go about generating value if funded.
That is insanely surprising to me. I’m continuously impressed by especially the volume of research, but also the quality that RP puts out (example for me is Schukraft 2020 (and in general the whole moral patienthood series), but also Zhang 2022 and Dillon 2021, Dillon 2021a and Dillon 2021b). To me it looks like you’re one of the only orgs that actually puts out research.
Rethink Priorities has a lot of capabilities to do this well but unfortunately we are very funding constrained from expanding this work.
Note that in this sentence by Peter, he is referring primarily to message-testing and related work. Not all projects/teams at RP are funding constrained (e.g. I would not classify our Longtermist Department as funding-constrained, in the sense of “funding is in my top 3- priorities as a manager on the team.” ).
Thanks! That’s a nice compliment! Luckily a lot of our research directions are fully funded and we do have a lot of funding overall, so we will keep putting out more work!
I’m very surprised to hear that this work is funding constrained. Why do you currently think this has received less interest from funders?
I wish I knew! My leading hypothesis is that (a) we still need to prove ourselves more with the money we have received and (b) I’ve done a bad job explaining how we would go about generating value if funded.
That is insanely surprising to me. I’m continuously impressed by especially the volume of research, but also the quality that RP puts out (example for me is Schukraft 2020 (and in general the whole moral patienthood series), but also Zhang 2022 and Dillon 2021, Dillon 2021a and Dillon 2021b). To me it looks like you’re one of the only orgs that actually puts out research.
Note that in this sentence by Peter, he is referring primarily to message-testing and related work. Not all projects/teams at RP are funding constrained (e.g. I would not classify our Longtermist Department as funding-constrained, in the sense of “funding is in my top 3- priorities as a manager on the team.” ).
Ok, that clarifies it & relieves me.
Thanks! That’s a nice compliment! Luckily a lot of our research directions are fully funded and we do have a lot of funding overall, so we will keep putting out more work!